SBIR/STTR Research Award
Novel Sorbent Technology for the Rapid Treatment of Acute Joint Injury and Inflammation
Award amount
$74,918Program and phase
SBIR · Phase IAward year
2023Award details
- Awarding agency
- Department of Defense
- Branch
- Air Force
- Recipient company
- CYTOSORBENTS MEDICAL INC
- Proposal award date
- 2023-05-12
- Contract end date
- 2023-08-10
- UEI
- LSF2KFUSY4K7
- Solicitation number
- X23.5
- Topic code
- AFX235-CSO1
Research abstract
Joint injuries, whether sustained during training or in the field, are a major source of lost duty days in the military. The immediate effects are severe pain, swelling and inflammation, which can compromise warfighter readiness and result in significant
Technology keywords
Not reported
Other awards by this recipient
Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.
- Novel Oral Sorbent Therapy for the Prevention and Treatment of Traveler’s Diarrhea
- Novel Extracorporeal Therapy for the Reversal of Septic Shock and Restoring Hemodynamic Stability
- Investigation of a potassium adsorber for the treatment of hyperkalemia induced by traumatic injury and acute kidney injury in austere medicine
- Development of an Effective Adsorber to Remove Anti-A and Anti-B Antibodies from Plasma for Transfusion
- pRBC Contaminant Removal with Hemocompatible Porous Polymer Beads
Awards with the same topic code
Verified by an exact topic code match. This is not a text-similarity match.
- Development of a Semi-autonomous Handheld Robotic Device to Enable Rapid Vascular Access By Non-specialists in Austere Environments
- Evitado TACFI
- AI for Adaptive 3D Infrastructure Design in Navy Engineering
- Smart Thermal Protection Systems for Hypersonics
- Sub-THz Reflectarrays: An Alternative Architecture for Enhanced Array Scaling with 3D Heterogeneous Integration for DoD ELGAR Use Cases
Research funding history
16 SBIR/STTR records share this UEI (2012–2023). Reported award amounts total $11,830,667. Reported amounts are not federal obligations.
Phases: Phase I, Phase II, Phase II – Direct to Phase II
Agencies: Department of Defense, Department of Health and Human Services